share_log

FSD Pharma | SC 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities (Amendment)

FSD Pharma | SC 13D/A:超过5%持股股东披露文件(修正)

美股SEC公告 ·  2021/02/22 11:35
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息